# Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

> **NCT02407782** · PHASE3 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 1092 (actual)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Permethrin

## Key facts

- **NCT ID:** NCT02407782
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-19
- **Primary completion:** 2021-12-16
- **Final completion:** 2022-01-18
- **Target enrollment:** 1092 (ACTUAL)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407782, "Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02407782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*